<!doctype html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7" lang=""> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8" lang=""> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9" lang=""> <![endif]-->
<!--[if gt IE 8]><!-->
<html class="no-js" lang=""> <!--<![endif]-->

<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    <title>experiment</title>

    <meta name="description" content="">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="stylesheet" href="header.css">
    <link rel="icon" href="./image/favicon (2).ico" type="image/x-icon">
    <link rel="stylesheet" href="huajing.css">
    <link rel="stylesheet" href="css/font-awesome.min.css">
    <link rel="stylesheet" href="css/main.css">
    <link rel="stylesheet" href="css/color1.css">

    <link href="assets/css/bootstrap.css" rel="stylesheet">


    <link href='http://fonts.googleapis.com/css?family=Lato:300,400,700,300italic,400italic' rel='stylesheet'
        type='text/css'>
    <script src="assets/js/jquery.min.js"></script>
    <script type="text/javascript" src="assets/js/smoothscroll.js"></script>
    <script src="assets/js/Chart.js"></script>
</head>



<body data-spy="scroll" data-offset="0" data-target="#nav">

    <!-- Preloader -->
    <div class="preloader"></div>
    <header style="overflow: visible;">
        <div class="nav-header">
            <p class="navbar-brand font-special">  Initial indicators for the prognosis of Acinetobacter Baumannii
                bacteremia in children
            </p>

        </div>

        <div id="wrap">

            <nav id="menu">
                <ul>
                    <li><a href="./index.html">Home</a></li>
                    <li><a href="introduction.html">Introduction</a>
                        <ul>
                            <li><a href="./introduction.html#background">Background</a></li>
                            <li><a href="./introduction.html#box2">Methods</a></li>
                            <li><a href="./introduction.html#box22">Results</a></li>
                            <li><a href="./introduction.html#box222">Conclusions</a></li>
                        </ul>
                    </li>
                    <li><a href="./index.html#portfolio">Team</a></li>
                    <li><a href="./experiment.html">Experiment</a>
                        <ul>
                            <li><a href="./experiment.html">Methods</a></li>
                            <li><a href="./experiment.html#box33">Results</a></li>
                            <li><a href="./experiment.html#box333">DATA</a></li>

                        </ul>
                    </li>
                    <li><a href="./contact.html">Else</a></li>

                </ul>
            </nav>
        </div>
    </header>


    <hr>
    </div>
    <section id="work" name="work"></section>
    <div id="box3">
        <div class="container desc">
            <div class="row" style="background-color: rgba(36, 124, 95, 0.541); ">
                <div>
                    <div class="col-lg-2 col-lg-offset-1">
                        <h5 style="color: aliceblue; background-color: rgba(36, 158, 32, 0.61); font-size: large;">
                            Methods
                        </h5>

                    </div>
                    <div class="col-lg-6">
                        <p style="color: aliceblue; background-color: rgba(36, 158, 32, 0.61); font-size: large;">
                            Clinical
                            data collection</p>
                        <p style="color: aliceblue;">All children admitted to the pediatric intensive care unit of
                            Children’s Hospital of Soochow
                            University with the isolation of AB from blood were enrolled from January 2018 to December
                            2022.
                            This study cohort comprised children aged 0.60-10.15 years.

                            Inclusion criteria of the patient was the following: (1) blood culture-confirmed AB
                            bacteremia;
                            (2)
                            AB-BSI that occurred 48 h after admission, and met the diagnostic criteria for bloodstream
                            infection; (3) on the day of specimen collection, the patient developed fever and had a
                            temperature
                            with more than 38.0 °C. Exclusion criteria was those including: (1) patients were detected
                            with
                            other pathogen from blood at the same time; (2) medical records was incomplete; (3) the
                            length
                            of
                            hospital stay was less than 48 h.

                            Data of patients, including demographics, symptoms and signs, laboratory data, and empiric
                            and
                            definite antimicrobial agents within 24 h of the onset of the disease, and invasive
                            manipulation
                            within 2 weeks prior to infection were collected from the clinical records retrospectively.
                            All
                            patients were divided into survival and death groups according to their outcomes within 30
                            days.
                            The
                            study procedures were conducted in accordance with the declaration of Helsinki. Written
                            informed
                            consent was obtained from the family involved. The study was reviewed by the Institutional
                            Review
                            Board in the hospital (ethics approval number: 2020CS069).</p>
                    </div>
                    <div class="col-lg-3">
                        <p style="color: aliceblue; background-color: rgba(36, 158, 32, 0.61); font-size: large;">
                            Strain
                            isolation and drug
                            susceptibility test</p>
                        <p style="color: aliceblue;">
                            <more>The blood was collected from children with suspected infections. Once the specimen was
                                obtained, it was immediately sent to the microbiology laboratory. The bacteria was
                                isolated
                                and
                                cultured according to the standard [13]. Bruker Bacteria Identification Mass
                                Spectrometer
                                (MALDI
                                Biotyper, Bruker, Germany) was used for identifying the type of bacteria. Drug
                                susceptibility
                                was measured by the instrument (VITEK2 Com-pact, Mérieux, France) and the disc agar
                                diffusion
                                method to measure the minimum inhibitory concentration. The evaluation of drug
                                susceptibility
                                adopted the 2020 standard of the American Clinical Laboratory Standardization Committee
                                [14].<br /><br />
                                <sm><i class="icon-tag"></i> </sm>
                            </more>
                        </p>
                    </div>
                </div>

                <div class="col-lg-6 col-lg-offset-3">
                    <p style="color: aliceblue;background-color: rgb(36, 158, 32);">Definitions</p>
                    <p style="color: aliceblue;">Bloodstream infection (BSI) was defined as pathogens isolated from
                        blood
                        cultures with clinical
                        manifestations consistent with sepsis syndrome [15]. Multidrug resistant (MDR) referred to the
                        2012
                        expert consensus on the diagnosis, treatment, prevention and control of AB infection in China
                        [16].
                        Neutropenia was defined as absolute neutrophil count (ANC) lower than 1500/µL peripheral blood.
                        Serious neutrophil was defined as neutrophil count lower than 500/µL. The
                        neutrophil-to-lymphocyte
                        ratio (NLR) was calculated as a simple ratio between the neutrophil and lymphocyte counts
                        measured
                        in peripheral blood.</p>
                </div>
                <div class="col-lg-3">
                    <p style="color: aliceblue;background-color: rgb(36, 158, 32);">Statistical analysis</p>
                    <p style="color: aliceblue;">
                        <more> The counting data was compared by the number of
                            cases or percentiles, and the Fishers exact probability method was used for the comparison
                            between groups. Multivariate Cox regression model was used to determine the independent risk
                            factors for death of 30 days. To determine the association between factors and mortality,
                            hazard
                            ratios (HRs) and 95% confidence intervals (CIs) were estimated with adjustment of
                            independent
                            risk factors. P < 0.05 was determined as statistically significant. </more>
                    </p>
                </div>
            </div>
        </div>
    </div>

    <!-- results -->
    <div id="box33">
        <div class="container desc">
            <div class="row">
                <div>
                    <div class="col-lg-2 col-lg-offset-1">
                        <h5 style="color: rgb(0, 0, 0);">results</h5>

                    </div>
                    <div class="col-lg-6">
                        <p style="color: rgb(0, 0, 0); background-color:#f4c9ae;">Demographics and clinical
                            characteristics
                        </p>
                        <p style="color: rgb(0, 0, 0) ;">Of the 37 children with AB-BSI included in this study, 23 were
                            males and 14 were females, with a median age of 4.83 (0.60 to 10.15) years, and there were
                            no
                            significant differences in gender and age between these two groups. Among these patients, 18
                            died (48.65%, 18/37) and 19 survived (51.35%, 19/37). The dead group had a significantly
                            higher
                            incidence of respiratory failure (p = 0.008), shock (p = 0.000), MODS (p = 0.000),
                            neutropenia (
                            < 1.5 × 109 /L) (p = 0.000) and serious neutropenia (< 0.5 × 109/L) (p = 0.000) than those
                                in the survival group. The median length of hospital stay before onset was 22 (10, 36)
                                days, and the median length of total hospital stay was 57 (33.5,105) days, of which
                                78.38% (29/37) had total hospital stay more than 30 days. The source of pathogen from
                                ICU ward (including PICU, NICU, SICU) accounted for 86.49% (32/37), and that from
                                general ward was 13.51% (5/37). The proportion of multidrug-resistant (also
                                carbapenem-resistance) AB in the death group was significantly higher than that in the
                                survival group (p = 0.000), while the PICS score was significantly lower in the survival
                                group than that in the death group (p = 0.000). There was no significant difference in
                                effective antibiotic use within 24 h between the two groups (p = 0.295) (Table 1).</p>
                    </div>
                    <div class="col-lg-3">
                        <p style="color: rgb(0, 0, 0);background-color:#f4c9ae;"> image</p>
                        <p style="color: aliceblue;">
                        <p><img class="img-responsive" src="./image/resulit.png" alt=""></p>
                        </p>
                    </div>
                </div>

                <div class="col-lg-6 col-lg-offset-3">
                    <p style="color: rgb(0, 0, 0);background-color:#f4c9ae;">Underlying disease</p>

                    <p style="color: rgb(0, 0, 0);">Among the 37 children with bloodstream infection of AB, 56.76%
                        (21/37)
                        patients with underlying diseases were haematological disorders and oncology, of which was
                        consisted
                        by 10.81% (4/37) acute lymphoblastic leukemia, 13.51% (5/37) acute myeloid leukemia, 2.70%
                        (1/37)
                        acute mixed cell leukemia, 5.41% (2/37) juvenile myelomonocytic leukemia, 8.11% (3/37) aplastic
                        anemia, 10.81% (4/37) lymphoma and 5.41% (2/37) hemophagocytic lymphohistiocytosis.The number of
                        children with hematologic diseases in the death group was significantly more
                        than that in the survival group (94.44% vs. 21.05%, p = 0.000). But the number of children with
                        neonatal systemic diseases in the survival group was significantly more than those in the death
                        group (31.58% vs. 0%</p>
                </div>
                <div class="col-lg-3">
                    <p style="color: rgb(0, 0, 0);background-color:#f4c9ae;"> image</p>
                    <p><img class="img-responsive" src="./image/Underlying disease.png" alt=""></p>
                </div>
            </div>
        </div>
    </div>


    <!-- Data -->
    <div id="box333" >
        <div class="container desc">
            <div class="row" style="background-color: rgba(36, 124, 95, 0.541);height: 500px; ">
                <div>
                    <div class="col-lg-2 col-lg-offset-1">
                        <h5 style="color: aliceblue; background-color: rgba(36, 158, 32, 0.61); font-size: large;">Data
                        </h5>

                    </div>
                    <div class="col-lg-6">
                        <p style="color: aliceblue; background-color: rgba(36, 158, 32, 0.61); font-size: large;">
                            Laboratory
                            indicators within 24 h of infection
                        </p>
                        <p><img class="img-responsive" src="./image/Data1.png" alt=""></p>
                        <p style="color: aliceblue;">Data Availability:
                            The datasets used and/or analysed during the current study are available from the
                            corresponding
                            author on reasonable request.</p>


                    </div>


                    <div class="col-lg-3">
                        <p style="color: aliceblue; background-color: rgba(36, 158, 32, 0.61); font-size: large;">
                            Analysis
                            of risk factors for death</p>
                        <p style="color: aliceblue;">
                        <p><img class="img-responsive" src="./image/Data2.png" alt=""></p>
                        <p><img class="img-responsive" src="./image/Data3.png" alt=""></p>
                        </p>
                    </div>
                </div>

            </div>
        </div>
    </div>

    <footer id="footer">
        <div class="container">
            <div class="row">
                <div class="col-md-12">
                    <ul class="list-inline social-buttons" style="display: flex;flex-direction: row;">
                        <li><a href="#"><i class="fa fa-facebook"></i></a>
                        </li>
                        <li><a href="#"><i class="fa fa-twitter"></i></a>
                        </li>
                        <li><a href="#"><i class="fa fa-linkedin"></i></a>
                        </li>
                        <li><a href="#"><i class="fa fa-youtube"></i></a>
                        </li>
                        <li><a href="#"><i class="fa fa-vimeo"></i></a>
                        </li>
                    </ul>
                </div>
                <div class="col-md-12">
                    <span class="copyright"> <em>Copyright &copy; <a target="_blank" href=""></a></em></span>
                </div>
            </div>
        </div>
    </footer>



    <!-- jQuery -->
    <script src="js/vendor/jquery.js"></script>
    <script src="js/script.js"></script>
    <script src="assets/js/bootstrap.js"></script>

</body>

</html>